Integration of a plasma protein binding factor to the Chemical-Specific Adjustment Factor (CSAF) for facilitating the estimation of uncertainties in interspecies extrapolations when deriving health-based exposure limits for active pharmaceutical ingredien
Keywords: API; ADE; OEL; Occupational exposure limits; Pharmacokinetics; PBPK modeling; PDE; Protein binding; RFD; Toxicological risk assessment;